Serotonin Metabolism Shapes the Tumor Immune Microenvironment and Serves as aTherapeutic Target in Lung Cancer

Serotonin deficiency in the tumor microenvironment of the lung suppresses antitumor immunity. Its restoration reverses immune dysfunction and limits tumor progression. These findings identify serotonin as a potential metabolic regulator and immunotherapeutic target in lung cancer.